Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (Denosumab) - Review

BACKGROUND: Denosumab, an anti-resorptive agent, IgG2 monoclonal antibody for human Receptor activator of nuclear factor-kappa B ligand (RANKL), has been related to the occurrence of osteonecrosis of the jaws. Thus, the aim of this study was to review the literature from clinical case reports, regar...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira, Camila-Carvalho, Brizeno, Luiz-André-Cavalcante, de Sousa, Fabrício-Bitu, Mota, Mário-Rogério-Lima, Alves, Ana-Paula-Negreiros-Nunes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920456/
https://www.ncbi.nlm.nih.gov/pubmed/26827069
http://dx.doi.org/10.4317/medoral.21044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920456/
https://www.ncbi.nlm.nih.gov/pubmed/26827069
http://dx.doi.org/10.4317/medoral.21044

Ejemplares similares